Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study

Conclusion: Treating patients hospitalized for COVID-19 with remdesivir is associated with a statistically significant reduction in 30-day COVID-19-related and all-cause readmission across variant time periods. These findings indicate that the clinical benefit of remdesivir may extend beyond the COVID-19 hospitalization.PMID:38420658 | DOI:10.57264/cer-2023-0131

Source: Journal of Comparative Effectiveness Research - February 29, 2024 Category: General Medicine Authors: Essy Mozaffari Aastha Chandak Robert L Gottlieb Chidinma Chima-Melton Andre C Kalil Vishnudas Sarda Celine Der-Torossian Thomas Oppelt Mark Berry Alpesh N Amin Source Type: research